Cardiology

Systematic review finds no increased intracranial haemorrhage risk with DOACs versus antiplatelets, reinforcing atrial fibrillation guidelines.

LGE imaging predicts sudden cardiac death in young HCM patients, improving risk models and informing clinical strategies.

Glycemic control influences brain connectivity and heart variability, with distinct age and sex differences in healthy adults.

VO2peak declines in Fabry disease, correlating with cardiomyopathy severity, suggesting its use as a marker for therapy response.

Novel study links coronary microvascular dysfunction to increased atherosclerotic plaque burden in INOCA, advancing cardiovascular insights.

Evolocumab improves endothelial function in cardiovascular patients, suggesting potential long-term benefits for heart health.

Stress echocardiography predicts five-year cardiovascular risk, guiding treatment for high-risk patients and offering reassurance for low-risk cases.

Alternative LDL cholesterol-lowering strategy offers similar outcomes to statins, with fewer side effects and better safety.